Chr. Hansen reports 5% organic growth and significant strategic progress in 2019/20
Delivers on guidance, launched new strategy and carried through three acquisitions in spite of COVID-19
Delivers on guidance, launched new strategy and carried through three acquisitions in spite of COVID-19
- Delivering on operational and strategic priorities while continuing to build long-term growth
Chr. Hansen realizes strong organic growth of 12% in the financial year 2015/16, delivering at the upper end of our Nature’s no. 1™ growth ambitions.
Chr. Hansen realizes strong organic growth of 10% in 2014/15, delivering at the upper end of the Nature's No. 1 growth ambition.
Chr. Hansen is a global, differentiated bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. At Chr. Hansen we are uniquely positioned to drive positive change through microbial solutions. We have worked for over 150 years to enable sustainable agriculture, better food and healthier living for more people around the world. Our microbial and fermentation technology platforms, including our broad and relevant collection of around 50,000 microbial strains, have game-changing potential. Matching customer needs and global trends we continue to unlock the power of good bacteria to respond to global challenges such as food waste, global health and the overuse of antibiotics and pesticides. As one of the world’s most sustainable companies, we touch the lives of more than 1 billion people every day. Driven by our legacy of innovation and curiosity to pioneer science, our purpose – To grow a better world. Naturally. – is at the heart of everything we do.
Boege Allé 10-12
DK-2970 Hoersholm
Denmark